Notably, the p-value of the overall survival of the patients bearing cancer with shallow CNV of BECN1 and BRCA1 was more significant in TP53 mutated than in the whole cohort (p = 0.0088 versus p = 0.0105) (Figure 4A and Figure 5A). The gene discussed is TP53; the disease is cancer.